Trial
NCT03318861
Study to Evaluate the Safety and Efficacy of KITE-585 in Participants With Relapsed/Refractory Multiple Myeloma
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Kite, A Gilead Company
Collaborators
—
Condition
Relapsed/Refractory Multiple Myeloma
Intervention
KITE-585
Why stopped
The study was terminated due to lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-10-19